ICU Medical Profit Margin 2006-2018 | ICUI
Current and historical gross margin, operating margin and net profit margin for ICU Medical (ICUI) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ICU Medical net profit margin as of December 31, 2018 is 2.06%.
| ICU Medical Annual Profit Margins |
|---|
| ICU Medical Quarterly Profit Margins |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.568B | $1.400B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $129.838B | 25.32 |
| Medtronic (MDT) | Ireland | $112.952B | 16.51 |
| Stryker (SYK) | United States | $67.256B | 24.66 |
| Boston Scientific (BSX) | United States | $48.820B | 23.72 |
| Baxter (BAX) | United States | $37.991B | 24.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.550B | 15.71 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.615B | 0.00 |
| Canopy Growth (CGC) | Canada | $14.912B | 0.00 |
| ResMed (RMD) | United States | $14.218B | 26.96 |
| Aurora Cannabis (ACB) | Canada | $9.118B | 64.29 |
| Bio-Rad Laboratories (BIO) | United States | $8.765B | 50.28 |
| Perrigo (PRGO) | Ireland | $6.633B | 10.75 |
| Hill-Rom Holdings (HRC) | United States | $6.374B | 19.72 |
| Insulet (PODD) | United States | $4.900B | 1642.60 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.701B | 0.00 |
| Haemonetics (HAE) | United States | $4.189B | 37.16 |
| Hutchison China MediTech (HCM) | China | $4.046B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $3.268B | 0.00 |
| Neogen (NEOG) | United States | $2.958B | 48.10 |
| NuVasive (NUVA) | United States | $2.784B | 24.18 |
| Quidel (QDEL) | United States | $2.365B | 21.17 |
| National Vision Holdings (EYE) | United States | $2.220B | 43.66 |
| Aphria (APHA) | $1.917B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.349B | 19.38 |
| VAREX IMAGING (VREX) | United States | $1.222B | 23.93 |
| Cardiovascular Systems (CSII) | United States | $1.190B | 854.00 |
| AtriCure (ATRC) | United States | $1.049B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.931B | 25.16 |
| Omeros (OMER) | United States | $0.908B | 0.00 |
| PetIQ (PETQ) | United States | $0.862B | 24.67 |
| MacroGenics (MGNX) | United States | $0.791B | 0.00 |
| Cerus (CERS) | United States | $0.787B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.737B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.689B | 0.00 |
| Evolus (EOLS) | United States | $0.681B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.666B | 22.66 |
| OraSure Technologies (OSUR) | United States | $0.594B | 25.86 |
| Surmodics (SRDX) | United States | $0.546B | 79.43 |
| LeMaitre Vascular (LMAT) | United States | $0.536B | 25.46 |
| Meridian Bioscience (VIVO) | United States | $0.531B | 15.82 |
| Quanterix (QTRX) | United States | $0.492B | 0.00 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.322B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.321B | 20.88 |
| Insys Therapeutics (INSY) | United States | $0.313B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.305B | 125.85 |
| Vapotherm (VAPO) | United States | $0.296B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.271B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.213B | 2.91 |
| Zynex (ZYXI) | United States | $0.171B | 18.31 |
| Chimerix (CMRX) | United States | $0.133B | 0.00 |
| Bovie Medical (APYX) | United States | $0.131B | 0.00 |
| Fonar (FONR) | United States | $0.125B | 6.68 |
| Chembio Diagnostics (CEMI) | United States | $0.121B | 0.00 |
| Surface Oncology (SURF) | United States | $0.113B | 0.00 |
| Female Health (VERU) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.088B | 20.06 |
| CAS Medical Systems (CASM) | United States | $0.072B | 0.00 |
| Neurotrope (NTRP) | United States | $0.071B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.071B | 21.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.070B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.043B | 0.00 |
| Senestech (SNES) | United States | $0.034B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.031B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.025B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.018B | 0.00 |
| InVivo Therapeutics Holdings (NVIV) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 13.71 |
